Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

AMRAMR

Financiado

Cerrado

Advanced Multidisciplinary Research for Antimicrobial Resistance

We are proposing a 4-year program of knowledge transfer and networking between academic institutions [University of Leicester (UK), University of Valencia (Spain), International Iberian Nanotechnology Lab (Portugal), University of... ver más

31/12/2027

UNIBO

Presupuesto desconocido

Líder del proyecto

ALMA MATER STUDIORUM UNIVERSITA DI BOLOGNA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-01-01

HORIZON-MSCA-2022-SE-01-01: MSCA Staff Exchanges 2022 ExpectedOutcome:

I+D

Cerrada hace 1 año

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

Participantes

UNIBO

Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PID2020-114347RB-C31 DISEÑO Y SINTESIS DE NANOPARTICULAS MOLECULARES Y BIOMOLECUL... 133K€ Cerrado

NANO-PROTECT Antimicrobial nano-coatings for hospital textiles to prevent... 165K€ Cerrado

PHOTO-IASIS Nanoengineered coatings for visible light photocatalytic dis... 192K€ Cerrado

PID2020-114347RB-C33 ACCIONES MECANOBACTERICIDAS DE LAS NANOPARTICULAS 99K€ Cerrado

PROMETHEUS Flame nanoengineering for antibacterial medical devices 2M€ Cerrado

PID2020-114347RB-C32 DISEÑO, SINTESIS, PROPIEDADES FOTOFISICAS Y ACTIVIDAD ANTIMI... 125K€ Cerrado

Duración del proyecto: 47 meses Fecha Inicio: 2024-01-01
Fecha Fin: 2027-12-31

Líder del proyecto

ALMA MATER STUDIORUM UNIVERSITA DI BOLOGNA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto We are proposing a 4-year program of knowledge transfer and networking between academic institutions [University of Leicester (UK), University of Valencia (Spain), International Iberian Nanotechnology Lab (Portugal), University of Bologna (Italy), University of Aveiro (Portugal), Fudan University (China), and Alfred University (USA)] and industrial partners [Teer Coatings Ltd (UK)]. The objective of the proposed joint exchange programme is to establish long-term stable research cooperation between the partners with interdisciplinary expertise and knowledge to develop Advanced Multidisciplinary Research for Antimicrobial Resistance (AMRAMR), including the development of novel antibacterial nanomaterials and nanostructures, novel antibacterial thin films coatings, upconversion technology for AMR applications, photonics technology for AMR application, and evaluation of the antibacterial performance and antimicrobial resistance; the synergetic effect for the above approaches to understanding antimicrobial resistance. Antimicrobial resistance (AMR) refers to the ability of microorganisms, such as bacteria, viruses, fungi, and parasites, to resist the effects of antimicrobial drugs, such as antibiotics, antivirals, antifungals, and antiparasitics. AMR is a serious global public health threat that could lead to increased morbidity, mortality, and healthcare costs.World Health Organisation (WHO) has declared that AMR is one of the top 10 global public health threats facing humanity. The COVID-19 pandemic has highlighted the importance of AMR as it has led to increased use of antimicrobial drugs, particularly antibiotics, which can contribute to the development of AMR. People with COVID-19 may develop secondary bacterial infections, such as pneumonia, and may be prescribed antibiotics to treat these infections. However, unnecessary use of antibiotics can lead to the emergence and spread of resistant bacteria, making it more difficult to treat infections in the future.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores